Clinical Trials

Showing trials with last updates posted in 2025.

NCT04925960 | TERMINATED | PHASE3
42 participants

Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-25
Start Date:
2022-11-10
Completion:
2025-02-28
Conditions
  • Pmm2-CDG
  • Phosphomannomutase 2 Deficiency
  • Phosphomannomutase 2 Congenital Disorder of Glycosylation
  • Phosphomannomutase II Congenital Disorder of Glycosylation
  • Phosphomannomutase II Deficiency
Interventions
  • DRUG
No Results Yet
NCT04400539 | RECRUITING | PHASE2
20 participants

The IMmunotherapy Pleural 5-ALA PDT

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-25
Start Date:
2022-05-09
Completion:
2026-05-09
Conditions
  • Mesotheliomas Pleural
  • Malignant Pleural Mesothelioma
Interventions
  • DEVICE
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page